Galapagos(GLPG) - 2023 Q1 - Quarterly Report

EXHIBIT 99.1 Galapagos and NovAliX enter into an integrated drug discovery collaboration Mechelen, Belgium and Strasbourg, France; 30 March 2023, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) and NovAliX today announced a strategic collaboration in which Galapagos' research and discovery capabilities and exclusively related employees based in Romainville, France, will be transferred to NovAliX, a drug discovery-focused Contract Research Organization. The agreement follows Galapagos' renewed focus on its ...